For citations:
Kashukh E.A., Poluektova E.A., Kudryavtseva A.V., Krasnov G.S., Kazey V.I., Sobolev P.D., Gremyakova P.V., Ivashkin V.T. Effect of Rifaximin and a Multi-Strain Probiotic on the Intestinal Microbiome and Cardiovascular Risk Indicators in Patients with Coronary Heart Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019;29(4):38-49. (In Russ.) https://doi.org/10.22416/1382-4376-2019-29-4-38-49